Estados Unidos · Plataformas y datos · MarketBeat

Royal Bank Of Canada Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

Publicado por MarketBeat · Estados Unidos hace 1 h

Royal Bank Of Canada dropped their price objective on shares of Eyepoint Pharmaceuticals from $5.00 to $1.00 and set a "sector perform" rating for the company in a research note…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Royal Bank Of Canada Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

También te puede interesar

Myriad to sell prenatal health testing business to Labcorp for $210M

Meet the college students trying to reverse an obscure ban on trading onion futures

Dario Amodei's AI Safety Warning Is Colliding With Anthropic's IPO Timeline

Best Tech Stocks Right Now

HSBC CEO warns the AI boom won’t make every data center a good bet

Product DNA and Climate Pacer Launch Solution to Uncover Supply Chain Climate Risks Beyond Tier 1

Royal Bank Of Canada Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

Compartir

También te puede interesar

Myriad to sell prenatal health testing business to Labcorp for $210M

Meet the college students trying to reverse an obscure ban on trading onion futures

Dario Amodei's AI Safety Warning Is Colliding With Anthropic's IPO Timeline

Best Tech Stocks Right Now

HSBC CEO warns the AI boom won’t make every data center a good bet

Product DNA and Climate Pacer Launch Solution to Uncover Supply Chain Climate Risks Beyond Tier 1